避妊ステロイドを摂取した若い女性の肝臓の変化. 肝臓の出血および肝臓の原発性腫瘍
JAMA
|February 16, 1976
まとめ
経口避妊ステロイドは,若い女性の肝臓腫瘍と関連している可能性があります. この研究では,良性および悪性肝臓腫瘍の両方が見つかり,その中には危険な出血を引き起こし,ホルモン関連の原因に関する懸念が高まっています.
科学分野:
- 肝臓病理学 肝臓病理学
- エンドクリノロジー エンドクリノロジー
- 腫瘍学 腫瘍学
背景:
- 主要肝臓腫瘍は若い女性ではまれである.
- 経口避妊ステロイドの使用は,出産年齢の女性の間で広く使用されています.
研究 の 目的:
- 避妊用ステロイドの使用と若い女性における肝臓原発腫瘍の発症の潜在的な関連性を調査する.
- これらの腫瘍の臨床的表象,管理,およびアウトカムを記述する.
主な方法:
- 主要肝臓腫瘍を患った13人の若い女性について,遡及的ケースシリーズ分析を行いました.
- 腫瘍の特徴,治療法,患者のアウトカムを含む医療記録のレビュー.
主要な成果:
- 13人の若い女性は,避妊ステロイドを摂取している間に,一次性肝腫瘍を発症しました.
- 9つの腫瘍は良性で,4つは悪性でした.
- 6つの腫瘍が破裂し,生命を脅かす出血を引き起こした.
- 結果は,成功した切除から切除不可能な疾患,そして手術中に1人の死亡まで様々でした.
結論:
- この発見は,避妊用ステロイドホルモンが,生育年齢の女性における肝臓原発腫瘍の発症における潜在的な病因的役割を果たす可能性があることを示唆している.
- 経口避妊薬を使用している女性の場合,肝臓腫瘍に対する監視の強化が正当化される可能性があります.
- この関連性を確認し,その背後にあるメカニズムを明らかにするために,さらなる研究が必要である.
関連する概念動画
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
